Head and Neck Cancer Trial, Recruiting NCT06607406 Sponsor: Wake Forest University Health Sciences Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT06607406
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a specific type of cancer called squamous cell carcinoma, confirmed by a laboratory test, located in the mouth, throat, voice box, lower throat, sinuses, or neck lymph nodes with an unknown starting point.
  • People whose treatment plan includes radiation therapy after surgery, with the goal of curing the cancer.
  • People with certain higher-risk features found during surgery (such as cancer spread to multiple lymph nodes, cancer growing into nerves or blood vessels, cancer cells found at or near the edges of the removed tissue, or cancer that has broken out of the lymph nodes), with the specific risk factors required depending on the type and location of the cancer (confirm with trial site).
  • People who have had their visible tumour completely removed by surgery, where the gap between that surgery and the planned start of radiation is more than 42 days but no more than 112 days.
  • People aged 18 or older at the time of joining the trial.
  • People who are in generally good physical condition, able to carry out normal daily activities with little or no limitation (what doctors call ECOG performance status 0–1).
  • People who are able to understand and sign a consent form (available in English or Spanish) and complete study-related tasks.

Who may not be able to join:

  • People whose head and neck cancer has come back after previously receiving radiation therapy, or after surgery followed by radiation therapy.
  • People who have developed a second, separate head and neck cancer after already being treated for a previous one.
  • People who have had radiation treatment to the head or neck area before, where any part of the new planned radiation field would overlap with an area that was previously treated.
  • People who currently have another active cancer (other than certain common skin cancers or very early-stage cancers that have not spread).
  • People whose head and neck cancer has spread to distant parts of the body or to lymph nodes outside the head and neck area.
  • People where the time between their primary surgery and the planned start of radiation therapy is more than 112 days.
  • People with serious uncontrolled health conditions, such as an active infection, uncontrolled heart failure, unstable chest pain, irregular heartbeat, or mental health or personal circumstances that would make it difficult to follow the study requirements.
  • People who are not considered suitable candidates for radiation therapy by their treating doctor — for example, people who are pregnant or planning to become pregnant, or anyone with another medical reason that makes radiation therapy unsuitable.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ryan Hughes, MD, Atrium Health Wake Forest Baptist Comprehensive Cancer Center

Phone: 336-713-6575

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 January 2025
Est. completion
1 January 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Locoregional Recurrence-free Survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov